在儿童癌症治疗后异常的HDL脂质和蛋白质组成:一个关联性研究
Véronique Bélanger1,2, Sophia Morel1,2, Mélanie Napartuk1,2
1Research Centre, CHU Sainte-Justine, 3175 Chem. de la Côte-Sainte-Catherine, Montreal, QC, H3T 1C5, Canada.
Lipids in health and disease
|June 10, 2023
概括
儿童癌症幸存者通常具有低高密度脂蛋白胆固醇 (HDL-C). 德克索鲁比暴露和肥胖影响治疗后早期的HDL组成,增加脂质失调风险.
科学领域:
- 儿科瘤学 儿科瘤学
- 心血管健康 心血管健康
- 脂质代谢 脂质代谢是什么
背景情况:
- 长期儿童癌症幸存者 (CCS) 面临高血脂不良的风险,特别是低高密度脂蛋白胆固醇 (HDL-C).
- 在CCS中,对低HDL-C的患病率和治疗在治疗完成后不久对HDL组成的影响的了解有限.
研究的目的:
- 为了调查儿童和青少年癌症治疗后的低HDL-C的患病率.
- 评估特定的癌症疗法,特别是多克索鲁比辛对高密度胆固醇组成和脂质水平的影响.
- 为了确定与这种人群中脱脂症相关的临床因素.
主要方法:
- 一项关联性研究分析了50名儿童和青少年在完成癌症治疗后4年内.
- 评估了临床特征,空腹血脂,阿波利波蛋白 (Apo A-I) 和高密度胆固醇 (HDL2,HDL3) 分数的组成.
- 后勤回归评估了低HDL-C的关联;在一个子组中,HDL组成与健康对照进行了比较.
主要成果:
- 16%的患者表现出较低的HDL-C,主要是诊断时的青少年.
- 较高的多克索鲁比辛剂量与降低的HDL-C和Apo A-I水平相关.
- 观察到异常的高密度胆固醇成分 (甘油三升高,降低雌性胆固醇),与多克索鲁比暴露和超重/肥胖有关.
结论:
- 早期的儿科癌症治疗后,HDL-C,Apo A-I和HDL组成的异常显而易见.
- 年龄,超重/肥胖和多克索鲁比暴露显著影响这些脂质异常.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
205
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
205
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K


